Cancer Medication recalls

The FDA has published 42 recalls involving cancer medication since 2014. The latest was reported on 18 Feb 2026. Most were for packaging defects. Attix Pharmaceuticals has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls42since 2014
Last 12 months3reported
Class I00% of total
Ongoing4latest 18 Feb 2026

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 40 95%Class III 2 5%

By year

Ongoing cancer medication recalls

4 active

All cancer medication recalls, newest first

42 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IITestosterone 75mg, Anastrozole 4mg, 1 Sterile Pellet recalledF.H. Investments Inc. (Particulate MatterNationwide
DrugCLASS IITestosterone 100mg Anastrozole 4mg , 1 Sterile Pellet recalledF.H. Investments Inc. (Particulate MatterNationwide
DrugCLASS IITestosterone 100mg, Anastrozole 4mg (4.5), 1 Sterile Pellet recalledF.H. Investments Inc. (Particulate MatterNationwide
DrugCLASS IIIMethotrexate Tablets, USP, 2.5mg recalled by Amneal PharmaceuticalsAmneal PharmaceuticalsOtherNationwide
DrugCLASS IIIMethotrexate Tablets, USP, 2.5 mg, Unit-Dose Tablets recalledMethotrexate SodiumWest-Ward ColumbusOtherMS, OH
DrugCLASS IIGemcitabine, Sterile Intravesical Solution recalled by Edge PharmaEdge PharmaSterilityNationwide
DrugCLASS IIImatinib Mesylate Tablets 100mg, packaged as a) bottles recalledDr. Reddy's LaboratoriesPotency & AssayNationwide
DrugCLASS IIImatinib Mesylate Tablets 100 mg recalled by Shilpa MedicareImatinib MesylateShilpa MedicareManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIImatinib Mesylate Tablets 400 mg recalled by Shilpa MedicareImatinib MesylateShilpa MedicareManufacturing (CGMP) DeviationsNationwide
DrugCLASS IITestosterone/Anastrozole Pellet 100/6 mg, 100 pellets recalledMasterPharmOtherNationwide
DrugCLASS IICisplatin Active Pharmaceutical Ingredient recalled by Johnson MattheyJohnson MattheyForeign MaterialNationwide
DrugCLASS IIAnastrozole Tablets, USP, 1 mg, a) recalled by American Health PackagingAnastrozoleAmerican Health PackagingProcessing DeviationNationwide
DrugCLASS IIAnastrozole Tablets, 1 mg recalled by Zydus Pharmaceuticals USAAnastrozoleZydus Pharmaceuticals USAManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIAnastrozole Tablets, USP, 1mg unit dose blisters recalledAnastrozoleAmerican Health PackagingProcessing DeviationNationwide
DrugCLASS IIAnastrozole Tablets, USP, 1 mg recalled by Zydus Pharmaceuticals USAAnastrozoleZydus Pharmaceuticals USAManufacturing (CGMP) DeviationsNationwide
DrugCLASS IILetrozole 2.5 mg tab recalled by Kroger Specialty PharmacyKroger Specialty PharmacyOther5 states
DrugCLASS IICapecitabine 150 mg Tablet recalled by Kroger Specialty PharmacyKroger Specialty PharmacyOther5 states
DrugCLASS IIImatinib Mesylate Tablet 400 mg recalled by Kroger Specialty PharmacyKroger Specialty PharmacyOther5 states
DrugCLASS IICyclophosphamide 50 mg cap recalled by Kroger Specialty PharmacyKroger Specialty PharmacyOther5 states
DrugCLASS IICapecitabine 500 mg Tablet recalled by Kroger Specialty PharmacyKroger Specialty PharmacyOther5 states
DrugCLASS IIAnastrozole USP for prescription compounding recalledAmerican Pharmaceutical IngredientsPotency & AssayNationwide
DrugCLASS IIAnastrozole SR recalled by KRS Global BiotechnologyKRS Global BiotechnologyOtherNationwide
DrugCLASS IIAnastrozole 0.5 mg Capsules, Rx Only, KRS Global Biotechnology recalledKRS Global BiotechnologyOtherNationwide
DrugCLASS IITestosterone 200 mg/Anastrozole 9 mg Pellet, Compounded recalledWells Pharmacy NetworkPotency & AssayTN
DrugCLASS IIAll Arimidex (anastrozole) Products recalledReliable Rexall-A Compounding PharmacyOtherCA, HI, NM
DrugCLASS IICapecitabine tablets USP 500 mg, Cytotoxic Agent recalledCapecitabineTeva North AmericaPotency & AssayNationwide
DrugCLASS IITestosterone/Anastrozole, Pellet, 120/8 mg recalled by JD & SN IncJD & SN IncSterilityNationwide
DrugCLASS IITestosterone/Anastrozole, Pellet, 200/13 mg recalled by JD & SN IncJD & SN IncSterilityNationwide
DrugCLASS IICapecitabine Tablets, USP, 500 mg recalled by Mylan PharmaceuticalsMylan PharmaceuticalsPotency & AssayNationwide
DrugCLASS IICarboplatin active pharmaceutical ingredient recalledAttix PharmaceuticalsPackaging DefectsNationwide

Should you stop taking Cancer Medication?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.